Echo IQ Limited (EIQ.AX)
- Previous Close
0.1050 - Open
0.1050 - Bid 0.1050 x --
- Ask 0.1100 x --
- Day's Range
0.1050 - 0.1050 - 52 Week Range
0.1000 - 0.2250 - Volume
263,805 - Avg. Volume
340,308 - Market Cap (intraday)
51.991M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Echo IQ Limited provides artificial intelligence diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. The company also EchoSolvTM, a software for identification Aortic Stenosis heart condition. It primarily serves physicians and health systems. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.
www.echoiq.aiRecent News: EIQ.AX
Performance Overview: EIQ.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EIQ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EIQ.AX
Valuation Measures
Market Cap
51.99M
Enterprise Value
50.22M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
578.30
Price/Book (mrq)
7.58
Enterprise Value/Revenue
584.01
Enterprise Value/EBITDA
-8.50
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-43.12%
Return on Equity (ttm)
-79.34%
Revenue (ttm)
781.57k
Net Income Avi to Common (ttm)
-6.41M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.77M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.4M
Company Insights: EIQ.AX
EIQ.AX does not have Company Insights